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Background: This study aimed to comprehensibly investigate potential contributing factors to fear of falling (FOF)
among people with idiopathic Parkinson’s disease (PD).
Methods: The study included 104 people with PD. Mean (SD) age and PD-duration were 68 (9.4) and 5 (4.2) years,
respectively, and the participants’ PD-symptoms were relatively mild. FOF (the dependent variable) was investigated
with the Swedish version of the Falls Efficacy Scale, i.e. FES(S). The first multiple linear regression model replicated a
previous study and independent variables targeted: walking difficulties in daily life; freezing of gait; dyskinesia;
fatigue; need of help in daily activities; age; PD-duration; history of falls/near falls and pain. Model II included also
the following clinically assessed variables: motor symptoms, cognitive functions, gait speed, dual-task difficulties and
functional balance performance as well as reactive postural responses.
Results: Both regression models showed that the strongest contributing factor to FOF was walking difficulties, i.e.
explaining 60% and 64% of the variance in FOF-scores, respectively. Other significant independent variables in both
models were needing help from others in daily activities and fatigue. Functional balance was the only clinical variable
contributing additional significant information to model I, increasing the explained variance from 66% to 73%.
Conclusions: The results imply that one should primarily target walking difficulties in daily life in order to reduce FOF
in people mildly affected by PD. This finding applies even when considering a broad variety of aspects not previously
considered in PD-studies targeting FOF. Functional balance performance, dependence in daily activities, and fatigue
were also independently associated with FOF, but to a lesser extent. Longitudinal studies are warranted to gain an
increased understanding of predictors of FOF in PD and who is at risk of developing a FOF.
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Approximately 75% of people with Parkinson’s disease
(PD) have an impaired balance [1], which constitutes
one of the most distressing symptoms [2]. People with
PD are particularly unstable when perturbed backwards
due to impaired postural reflexes [3-5], which is sug-
gested to be evaluated clinically by using an unexpected
shoulder pull [6]. Already early during the disease, tur-
ning difficulties are common [7] and an unsteadiness
while turning is also associated with having more severe
freezing of gait (FOG) [8]. Walking difficulties are also
common and mainly characterized by a decreased gait
speed and shuffling gait. Gait and balance problems are* Correspondence: Maria_H.Nilsson@med.lu.se
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stated.also related to non-motor features (e.g. cognitive dys-
function) of PD and are exacerbated by dual tasking [9].
People with PD have an increased risk of falling as
compared to healthy individuals at the same age, but
also in relation to people with other neurological disor-
ders [10-12]. They usually fall while performing activities
such as walking, turning, transferring to/from sitting,
bending forwards or while reaching [13]. It is also com-
mon for people with PD to experience near falls, which
can be defined as “a fall initiated but arrested by support
from a wall, railing, other person, etc.” [14]. A recent re-
view scrutinized specific factors associated with recur-
rent falls among people with PD, and fear of falling
(FOF) was then highlighted as one of the risk factors
[15]. In addition, FOF has been shown to be a predictor
for community walking [16] and a major barrier toral Ltd. This is an Open Access article distributed under the terms of the Creative
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of confidence (low self-efficacy [18]) to be able to per-
form activities without falling, i.e. low fall-related self-
efficacy.
Among people with PD, FOF is common and about
70% report activity limitations due to FOF, which also
may cause social isolation [10,19]. Although FOF influ-
ences activity and participation negatively among people
with PD, there is yet limited knowledge regarding con-
tributing factors. Such knowledge is highly warranted in
order to develop means that efficiently tap causal factors.
At present, there are four published studies that used
multivariate analysis to investigate contributing factors
to FOF in PD [1,20-22]. Two out of these four studies
were postal surveys and lacked clinical data [1,21], and
none of them have been replicated [1,20-22]. More im-
portantly, no study has included independent variables
targeting functional balance performance, dual tasking,
and gait speed or used an unexpected shoulder pull
when assessing postural instability. Since gait speed and
functional balance performance have been shown to cor-
relate to FOF in bivariate analyses [23,24], these aspects
may tentatively be of importance when investigating
contributing factors to FOF. Dual-tasking might also be
of interest since it worsens gait impairments in PD and
may lead to wrong prioritization, i.e. the “posture se-
cond” strategy [9,25]. There is thus a need for a more
thorough understanding of contributing factors to FOF
in PD in order to address this efficiently in clinical prac-
tice and research.
This study aimed at determining factors associated
with FOF (conceptualized as low fall-related self-efficacy)
among people with PD. More specifically, the aim was to
determine whether previous postal survey based findings
could be replicated in an independent clinical sample and,
secondly to investigate whether additional and previously
unexplored motor aspects (e.g. gait speed, functional ba-
lance performance) as well as cognitive features indepen-
dently may contribute to FOF.
Methods
All people diagnosed with PD receiving care at a south
Swedish university hospital during 2007–2011 were con-
sidered eligible for inclusion (n = 273). Exclusion criteria
were age above 80 years old (n = 106), inability to stand
without support (n = 17), inability to understand instruc-
tions (n = 8) or being mentally or medically unstable
(n = 7). The remaining 135 patients were invited to par-
ticipate. Twenty-eight (12 women) participants declined
to participate, and they did not differ significantly (p ≥
0.07, the Mann–Whitney U test) from the included ones
with respect to age and PD-duration. Three additional
participants (2 women) were excluded due to missing
data on the dependent variable: the Swedish version ofthe Falls Efficacy Scale, i.e. FES(S). The final study sam-
ple consisted of 104 participants.
Ethics statement
The Regional Ethical Review Board in Lund (Sweden)
approved the study (Dnr 2011/768). All participants gave
written informed consent.
Instruments
Demographic questions included, e.g., age, sex and di-
sease duration. Additional questions (no/yes responses)
included experience of falls during the past six months
[26], near falls [14], dual-task difficulties (“Do you experi-
ence balance problems when doing more than one thing
at a time, e.g. carrying a tray while walking?”) and pain
(“Do you presently suffer from pain?”). For descriptive
purposes, an additional dichotomous question (no/yes)
specifically targeted FOF.
A battery of self-reported questionnaires was included.
FES(S) targets fall-related self-efficacy, and includes 13
items (activities) rated from 0 (not confident at all) to
10 (completely confident) [23,27]. The maximum total
score is 130 and higher scores denote “better” balance
confidence. The self-administered version [8] of the free-
zing of gait questionnaire (FOGQsa) [28] consists of six
items scored 0–4 (higher scores =more difficulties). In
this study, we only used items 3 (freezing) and 6 (turning
hesitations). Those scoring ≥1 on item 3 were catego-
rized as “freezers” and those scoring ≥1 on item 6 were
considered as having turning hesitations [1]. The generic
Walk-12 (Walk-12G) assesses walking difficulties in
everyday life, and the total score ranges from 0 to 42
(higher scores =more walking difficulties) [29]. The
Functional Assessment of Chronic Illness Therapy - Fa-
tigue scale (FACIT-F) consists of 13 items with a total
score ranging from 0 to 52 (higher scores = less fatigue)
[30,31]. The Parkinson's disease Activities of Daily Living
Scale (PADLS) is a five-grade (5 = worse) single-item
scale regarding ADL-difficulties [32,33]. Those scoring >2
were categorized as “needing help from others in daily
activities”.
Before clinical assessments, all participants self-rated
their motor status at the time of examination as “good/
on”, “on with dyskinesias”, or “bad/off”. Clinical assess-
ments targeted functional balance, retropulsion due to
abnormal reactive postural responses, gait speed, par-
kinsonian motor status and cognition. The Berg balance
scale (BBS) was used to assess functional balance per-
formance of importance in daily life [34]. It includes 14
items (tasks) scored 0–4, and the maximum score is 56
(56 = better) [34,35]. The Nutt retropulsion test (NRT)
assesses reactive postural responses [6,36]. The patient
then stands with eyes open and feet slightly apart; the
examiner stands behind the patient and gives (without
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to the shoulders. Only one trial was performed (scored
0–3, 3 = worse) [6], and those scoring ≥1 were catego-
rized as having abnormal reactive postural responses.
The 10-meter walk test (10MWT) was used to measure
gait speed [35]. It was performed in both comfortable
and fast walking speed (randomized order, two trials
each). In this study, we only used comfortable gait speed
and a total distance of 14 meters, from which gait speed
(m/s) was calculated for the mid 10 meters. The trial with
the highest comfortable gait speed was used in the ana-
lyses. Parkinsonian motor symptoms were assessed with
the Unified PD Rating Scale (UPDRS) part III (motor
examination) [35,37]. It consists of 14 items (graded 0–4)
with a total score ranging from 0 to 108 (108 = worse). In
addition, dyskinesia was self-rated using part IV (compli-
cations of therapy) of the UPDRS; those scoring ≥1 on
item 32 (dyskinesia duration) were categorized as having
dyskinesias [37]. The Mini-Mental State Examination
(MMSE) was used as a coarse cognitive test [38], and
yields a total score ranging between 0–30 (30 = better).Procedure
All participants were assessed during an outpatient visit,
which was scheduled at a time of day when the par-
ticipant usually reported to feel at best. First, the par-
ticipants completed the self-administered questionnaire
booklet. Thereafter, all participants were evaluated by
the same physical therapist (BL). Clinical assessments
were performed in the following order: BBS; NRT; 10
MWT; UPDRS part III; and the MMSE. These were
followed by additional self-administered questions tar-
geting dyskinesia and demographic information.Statistical analyses
Data were checked regarding underlying assumptions
and described and analyzed accordingly using IBM SPSS
version 19. The alpha level of significance was set at
0.05 (2-tailed, exact P-values were used). Spearman cor-
relations (rs) and Mann–Whitney U-tests were used for
bivariate analyses of associations with the dependent vari-
able FES(S). Forward multiple linear regression models
were used based on the results from a recently published
study [1]. In our first model, we replicated the model iden-
tified by Nilsson et al. [1] by using age, disease duration,
walking difficulties, fatigue, need help from others in daily
activities, turning hesitations, freezing of gait, dyskinesia,
experiencing falls or near falls, and pain as independent
variables. In our second model, we explored the effects
of taking dual-task difficulties and variables based on
clinical examination, i.e., parkinsonian motor symptoms
(UPDRS III), cognition (MMSE), balance (NRT, BBS)
and gait speed (10MWT) into account as additionalindependent variables. Models were checked regarding
underpinning assumptions.
Results
Sample characteristics and results from bivariate ana-
lyses are presented in Table 1. According to the dichot-
omous FOF-question, 38 out of 104 (37%) participants
reported having FOF. FES(S) scores demonstrated sig-
nificant bivariate associations with all variables but gen-
der. The median FES(S) score was 117 (q1-q3, 69.5-129;
min-max, 11–130). At the time of assessments, 91 out of
the 104 participants (87.5%) rated their motor status as
“on”, whereas 9 (8.7%) rated it as “on with dyskinesias”,
and four (3.8%) rated it as “off”.
The first multiple linear regression based on the re-
sults from Nilsson et al. [1] resulted in three significant
independent variables explaining 66% of variance in
FES(S) scores (Table 2). The strongest independent vari-
able (as assessed by the standardized regression coeffi-
cients, β) was walking difficulties (Walk-12G scores),
which could account for 59.5% of the variance in FES(S)
scores. This was followed by fatigue and needing help
from others in daily activities (Table 2).
Adding information about the occurrence of dual-task
difficulties and clinical assessments as independent vari-
ables resulted in a model with four independent variables
explaining 73% of variance in FES(S) scores (Table 3). The
three variables identified in the first model remained sig-
nificant also in the second model, and the only variable
that contributed additional explanatory power was func-
tional balance (BBS). The strongest independent variable
was still walking difficulties, followed by functional bal-
ance, needing help from others in daily activities and fa-
tigue (Table 3).
Discussion
By comprehensibly investigating contributing factors to
FOF among people with PD and by using multivariate
analyses, this study confirms previous observations sug-
gesting that walking difficulties in daily life is the stron-
gest contributing factor in addition to independence in
daily activities and fatigue. Although some previous PD-
studies have shown similar results [1,20], none included
independent variables that targeted functional balance
performance, dual-task difficulties, and gait speed. A no-
vel finding in this study is that functional balance (that
is of importance in daily activities) was identified as an
additional significant independent contributor to FOF,
whereas a reactive postural response after an external
perturbation (and other motor or cognitive aspects) was
not. Including functional balance performance in the
model increased the explanatory power from 66% to 73%,
whereas other motor and cognition aspects do not appear
to provide any improvements beyond the first model. The
Table 2 Model I (replication [1]): multiple linear regression with fear of falling (FES(S) scores) as the dependent
variable in people with Parkinson’s disease, n = 104a
Adjusted R2
Significant independent variablesb B (95% CI) β P-value Stepwise change Cumulative
Walking difficulties (Walk-12G) −1.844 (−2.423, −1.266) −0.524 0.000 0.595 0.595
Need help from others in daily activities (PADLS) −24.960 (−40.672, −9.247) −0.213 0.002 0.042 0.637
Fatigue (FACIT-F) 0.667 (0.165, 1.169) 0.214 0.010 0.021 0.658
aIndependent variables in the analysis were: need help from others in daily activities (PADLS: dichotomized, 1 = yes), walking difficulties (Walk-12G), fatigue (FACIT-F),
age (years), PD-duration (years), falls (1 = yes), near falls (1 = yes), dyskinesia (dichotomized, 1 = yes), freezing (FOGQsa item 3: dichotomized, 1 = freezing), turning
hesitations (FOGQsa item 6: dichotomized, 1 = turning hesitations), pain (dichotomized, 1 = yes).
bListed by order of entry into the model (forward method).
FACIT-F, the Functional Assessment of Chronic Illness Therapy-Fatigue scale (0–52; higher = better); FES(S), Falls Efficacy Scale (0–130; higher = better); FOGQsa,
Freezing of Gait Questionnaire, self-administered version (items are scored 0–4; higher = worse); PADLS, The Parkinson’s disease Activities of Daily Living Scale
(1–5; higher =worse; those scoring >2 were categorized as needing help from others in daily activities) Walk-12G, 12-item generic walking scale (0–42; higher =worse).
B: regression coefficient; CI: confidence interval; β: standardized regression coefficient.






Age (years), mean (SD) 68 (9.4) −0.270 0.006
PD-duration (years), mean (SD) 5 (4.2) −0.350 <0.001
Cognition (MMSE), median (q1-q3) 28 (26–29) 0.220 0.027
Motor symptoms (UPDRS III), median (q1-q3) 13 (8–20) −0.510 <0.001
Balance (BBS), median (q1-q3) 52.5 (46–55) 0.650 <0.001
Gait speed (10MWT) (m/s), median (q1-q3) 1.18 (0.95–1.35) 0.480 <0.001
Walking difficulties (Walk-12G), median (q1-q3) 8 (4.5–21) −0.760 <0.001
Fatigue (FACIT-F), median (q1-q3) 38 (29–44) 0.710 <0.001
n (%)a Median (q1-q3) FES(S) scoresa P-value Mann Whitney U-test
No Yes No Yes
Freezing of gait (item 3, FOGQsa)b 60 (58) 44 (42) 128 (112–130) 87 (44–117) <0.001
Turning hesitations (item 6, FOGQsa)c 68 (65) 36 (35) 126 (105–130) 81 (39–113) <0.001
Dyskinesias (item 32, UPDRS IV)d 66 (63) 38 (37) 124 (95–129) 101 (48–125) 0.009
Need help from others in daily activities (PADLS)e 93 (90) 11 (10) 122 (94–129) 33 (18–50) <0.001
Experienced falls 76 (73) 28 (27) 124 (96–130) 89 (41–114) <0.001
Experienced near falls 64 (62) 39 (38) 127 (106–130) 91 (43–116) <0.001
Experienced balance problems while dual-tasking 52 (50) 52 (50) 128 (111–130) 94 (51–118) <0.001
Pain 78 (75) 26 (25) 123 (94–130) 91 (43–124) 0.005
Retropulsion (NRT)f 78 (75) 26 (25) 124 (83–130) 104 (59–120) 0.011
Female gender 55 (53) 49 (47) 118 (87–129) 113 (61–129) 0.258
aRefers to the dichotomous (No/Yes) variables, and n (%) clarifies the number (percentage) of participants that either have or do not have the specified characteristic.
bItem 3 (“freezing”) of the FOGQsa. Those scoring ≥1 were categorized as freezers.
cItem 6 (“turning hesitations”) of the FOGQsa. Those scoring ≥1 were categorized as having turning hesitations.
dItem 32 of the UPDRS part IV. Those scoring ≥1 were categorized as having dyskinesias.
eThose scoring >2 on the PADLS were categorized as needing help from others in daily activities.
fScores ≥1 on the NRT were categorized as having retropulsion.
BBS, Berg Balance Scale (possible scores, 0–56; higher = better); FACIT-F, the Functional Assessment of Chronic Illness Therapy - Fatigue scale (possible score, 0–52;
higher = better); FES(S), Falls Efficacy Scale, Swedish version (possible scores, 0–130; higher = better); FOGQsa, Freezing of Gait Questionnaire, self-administered
version; MMSE, Mini Mental State Examination (possible scores, 0–30; higher = better); NRT, Nutt Retropulsion Test (possible scores, 0–3; higher = worse); PADLS,
the Parkinson’s disease Activities of Daily Living Scale (possible scores 1–5; higher = worse); PD, Parkinson’s disease; q1-q3, 1st-3rd quartile; SD, standard deviation;
UPDRS III, part III (motor score) of the Unified PD Rating Scale (possible scores, 0–108; higher = worse); UPDRS part IV (complications of therapy), item 32 (possible
scores 0–4; higher = worse); 10MWT, 10-meter walking test; m/s, meters per second; Walk-12G, 12-item generic walking scale (possible scores, 0–42; higher = worse).
One participant had a missing value for the MMSE, and another participant had a missing value in relation to near falls.
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Table 3 Model II (extended): multiple linear regression with FES(S) scores as the dependent variable in people with
Parkinson’s disease, n = 104a
Adjusted R2
Significant independent variablesb B (95% CI) β P-value Stepwise change Cumulative
Walking difficulties (Walk-12G) −1.543 (−2.118, −0.968) −0.446 0.000 0.642 0.642
Need help from others in daily activities (PADLS) −21.823 (−35.841, −7.806) −0.189 0.003 0.045 0.687
Functional balance (BBS) 0.877 (0.333, 1.422) 0.221 0.002 0.027 0.714
Fatigue (FACIT-F) 0.547 (0.103, 0.991) 0.179 0.016 0.014 0.728
aIndependent variables in the analysis were: need help from others in daily activities (PADLS: dichotomized, 1 = yes), walking difficulties (Walk-12G), fatigue (FACIT-F),
age (years), PD-duration (years), falls (1 = yes), near falls (1 = yes), dyskinesia (item 32 UPDRS part IV: dichotomized, 1 = yes), freezing (FOGQsa item 3: dichotomized, 1
= freezing), turning hesitations (FOGQsa item 6: dichotomized, 1 = turning hesitations), pain (dichotomized, 1 = yes), cognition (MMSE), motor symptoms (UPDRS III),
Balance (BBS), 10-meters walk test (comfortable gait speed), Nutt Retropulsion test (dichotomized, 1 = abnormal reactive postural response), self-reported dual-task
difficulties (dichotomized, 1 = yes).
bListed by order of entry into the model (forward method).
BBS, Berg balance scale, 0–56 (higher = better); FACIT-F, the Functional Assessment of Chronic Illness Therapy-Fatigue scale (0–52; higher = better); FES(S), Falls
Efficacy Scale (0–130; higher = better); FOGQsa, Freezing of Gait Questionnaire, self-administered version (items are scored 0–4; higher = worse); MMSE, the
Mini-Mental State Examination (possible scores, 0–30; higher = better); PADLS, the Parkinson’s disease Activities of Daily Living Scale (1–5; higher = worse; those
scoring >2 were categorized as needing help from others in daily activities); PD, Parkinson’s disease; Walk-12G, 12-item generic walking scale (0–42; higher =
worse); UPDRS III: motor part of the Unified PD Rating Scale; UPDRS IV: motor complications.
B: regression coefficient; CI: confidence interval; β: standardized regression coefficient.
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sical therapy and rehabilitation targeting PD.
Several variables that showed highly significant bivari-
ate relationships with FOF (e.g. cognition and falls) were
not independently associated with FOF when controlling
for other independent variables. This illustrates a major
pitfall in relying on bivariate analyses and highlights the
importance of using multivariate analyses in this type of
studies. Although it may appear surprising that falls did
not contribute to FOF, this finding is in line with other
PD-studies using multivariate analyses [1,20,22].
Our first regression model represents an independent
replication of a prior study based on self-reported postal
survey data [1]. The replication corroborates walking dif-
ficulties as a major contributing factor to low fall-related
self-efficacy. This implies that walking difficulties should
be a primary target when attempting to reduce FOF.
Although generally confirming previous findings, the
present study did not identify turning hesitations as an
independent contributor to FOF as shown in the study
by Nilsson et al. [1]. This discrepancy is probably not re-
lated to differences in the dependent variable (i.e. FOF,
operationalized as low fall-related self-efficacy), since the
present median FES(S) score was similar to the one ob-
tained in the study by Nilsson et al. (117 and 114, re-
spectively) [1]. However, sample differences may still
have contributed, as the present sample seemed to be
less affected by their PD than the previous sample, e.g.
proportions of fallers (33% versus 45% in the study by
Nilsson et al. [1]) and of people needing help in daily ac-
tivities (10% here versus 27%). An alternative explan-
ation for the discrepancy may be that all independent
variables were not identically assessed in the two studies.
Walking difficulties in daily life was identified as a
major explanatory variable in both models, accountingfor almost two thirds of the variance in FES(S) scores.
This suggests that walking ability may be a primary the-
rapeutic target for alleviating FOF. Functional balance
performance (BBS scores) was significantly associated
with FOF, whereas the NRT was not. The clinical im-
plication of this finding is that balance training probably
should focus on challenges induced by self-generated per-
turbations rather than external perturbations, if aiming at
reducing FOF. In other words, it seems like interventions
should target functional balance performance and not
reactive postural responses if aiming at reducing FOF
among people with mild PD.
FOF among people with PD needs specific attention
since it has been identified as a risk factor for recurrent
falls [15], a barrier for exercise [17], and a predictor for
community walking [16]. Furthermore, FOF causes ac-
tivity restrictions and avoidance as well as social iso-
lation [10,19,23]. A recent Cochrane review concluded
that physical therapy can yield short-term improvements
in walking, mobility and balance as compared with no
intervention in people with PD [39]. However, the review
did not support reduction of FOF by physical therapy.
This may be explained by several factors. For example,
few of the reviewed studies included FOF as an outcome;
compromised methodological quality of the included stu-
dies; or that the key ingredients of the interventions did
not address walking difficulties in daily life. Future trials
targeting walking ability and including FOF as an outcome
are thus needed. Importantly, FOF may be such a complex
construct that it best benefits from using an interdisciplin-
ary approach. The latter may be supported by the fact that
dependence in daily activities as well as fatigue was inde-
pendently associated with FOF. Interestingly, it has been
suggested that poor walking economy among people with
PD may contribute to fatigue [40]. However, the exact role
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and cannot be addressed based on the current study.
Limitations and future perspectives
This sample consisted of people with PD that were rela-
tively mildly affected by their disease, which is mirrored
by several of the descriptive variables, e.g. motor symp-
toms (UPDRS III), PD duration, gait speed, and the
number of participants that had experienced falls. In
addition, people being above the age of 80 years were
not included. Our findings may thus not apply to very
old people with PD or those with more severe PD. It
should also be acknowledged that although several inde-
pendent variables were included, there may be additional
variables of importance for FOF such as general self-
efficacy, environmental factors, anxiety and depression.
In fact, a previous study that used multivariate analyses
showed that greater depression contributed to perceived
consequences of falling while anxiety contributed to ac-
tivity avoidance due to the risk of falling [21]. However,
ADL-difficulties showed a stronger independent associ-
ation with activity avoidance than anxiety did. It should
be noted that the study included few independent vari-
ables (disease severity, ADL, depression and anxiety),
and the influence of anxiety and depression on FOF
remains unclear due to the cross-sectional design of the
study.
In the present study, some of the variables that did not
show independent associations with FOF were assessed
by relatively coarse indicators, e.g. dual-task difficulties
and cognition (MMSE). By using a coarse indicator one
may not capture those having mild problems. For in-
stance, it has been suggested that the Montreal Cogni-
tive Assessment (MoCA) is preferably to MMSE when
screening for early cognitive impairments in PD [44,45].
Finally, due to the cross-sectional design of this study, it
cannot be establish whether the identified associated fac-
tors actually are predictive of FOF. Longitudinal studies
are needed to gain an increased understanding of risk
factors for developing FOF, but also for determining fac-
tors that may aggravate existing FOF over time. Such
knowledge is imperative to maximize the potential of in-
terventions aiming at reducing FOF.
Conclusions
This study was able to replicate previous main findings
in an independent sample of people with PD by identify-
ing everyday walking difficulties as a primary FOF asso-
ciated factor, and additional independent contributions
by fatigue and the need for help in daily activities. Fur-
thermore, functional balance performance was found to
be the only factor among a range of additional clinical
motor and cognitive variables that was able to account
for additional significant proportions of the variance inFOF. These observations imply that walking difficulties
and balance performance in daily life are candidate the-
rapeutic targets in order to reduce FOF in PD. However,
longitudinal studies are warranted in order to gain an in-
creased understanding of predictors of FOF in PD and
who is at risk of developing a FOF.
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